SCHEMBL3397985

SCHEMBL3397985

N#Cc1ccc(-c2ccnc(N)c2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 4/20 0.54
MKNK1 Q9BUB5 1/20 0.53
MKNK2 Q9HBH9 1/20 0.53
MAP4K4 O95819 1/20 0.51
AAK1 Q2M2I8 2/20 0.46
CDC7 O00311 1/20 0.46
CDK2 P24941 1/20 0.46
PDPK1 O15530 1/20 0.45
CYP11B2 P19099 1/20 0.44
HRH4 Q9H3N8 1/20 0.44
MYC P01106 1/20 0.44
MMP3 P08254 1/20 0.44
GSK3B P49841 1/20 0.43
LIMK1 P53667 1/20 0.43
EGLN2 Q96KS0 2/20 0.43
MAPKAPK2 P49137 2/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29432635 1.00 DYRK1A (0.54) DYRK1AMKNK1MKNK2MAP4K4AAK1
SCHEMBL30337203 0.84 DYRK1A (0.70) DYRK1AMKNK1MKNK2AAK1PDPK1
SCHEMBL18998664 0.82 CLK4 (0.59) DYRK1AMAP4K4CDC7CDK2GSK3B
SCHEMBL30935767 0.79 DYRK1A (0.63) DYRK1AMKNK1MKNK2AAK1PDPK1
SCHEMBL4402187 0.79 DYRK1A (0.63) DYRK1AMKNK1MKNK2AAK1PDPK1
SCHEMBL23809629 0.79 MYC (0.57) DYRK1AMKNK1MKNK2AAK1PDPK1
SCHEMBL23809618 0.79 DYRK1A (0.45) DYRK1AMKNK1MKNK2AAK1CDC7
SCHEMBL15649966 0.78 DYRK1A (0.63) DYRK1AMKNK1MKNK2AAK1PDPK1
SCHEMBL31294130 0.78
SCHEMBL312451 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12291516-B2 Substituted 1-amino-1H-imidazole-5-carboxamide as Bruton's tyrosine kinase inhibitors HENAN ZHIWEI BIOMEDICINE CO., LTD. (CN) 2025-05-06 US disclosed
EP-3966204-B1 SUBSTITUTED 1-AMINO-1H-IMIDAZOLE-5-CARBOXAMIDE AS BRUTON'S TYROSINE KINASE INHIBITORS HENAN ZHIWEI BIOMEDICINE CO LTD (CN) 2024-11-27 EP disclosed
CN-111909133-B Substituted 1-amino-1H-imidazole-5-carboxamides as inhibitors of brunauer tyrosine kinase 河南知微生物医药有限公司 2023-07-14 CN disclosed
US-20220259181-A1 SUBSTITUTED 1-AMINO-1H-IMIDAZOLE-5-CARBOXAMIDE AS BRUTON'S TYROSINE KINASE INHIBITORS HENAN ZHIWEI BIOMEDICINE CO., LTD. (CN) 2022-08-18 US disclosed
WO-2020228637-A1 SUBSTITUTED 1-AMINO-1H-IMIDAZOLE-5-CARBOXAMIDE AS BRUTON'S TYROSINE KINASE INHIBITORS HENAN NORMAL UNIVERSITY (CN) 2020-11-19 WO disclosed
CN-111909133-A Substituted 1-amino-1H-imidazole-5-carboxamides as brunauer tyrosine kinase inhibitors 河南师范大学 2020-11-10 CN disclosed
WO-2010046780-A2 ANTI VIRAL COMPOUNDS INSTITUT PASTEUR KOREA (KR) 2010-04-29 WO disclosed
WO-2010046780-A2 ANTI VIRAL COMPOUNDS INSTITUT PASTEUR KOREA (KR) 2010-04-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220259181-A1 SUBSTITUTED 1-AMINO-1H-IMIDAZOLE-5-CARBOXAMIDE AS BRUTON'S TYROSINE KINASE INHIBITORS BTK, SYK, TYK2 DYRK1A 114/4885MKNK1 674/4885MKNK2 767/4885
US-12291516-B2 Substituted 1-amino-1H-imidazole-5-carboxamide as Bruton's tyrosine kinase inhibitors BTK, SYK, TYK2 DYRK1A 114/4885MKNK1 674/4885MKNK2 767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.